Chitosan: Applications in Drug Delivery System

Carregando...
Imagem de Miniatura
Citações na Scopus
8
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
BENTHAM SCIENCE PUBL LTD
Autores
KUMAR, Suresh
DHIMAN, Ruby
PRUDENCIO, Carlos R.
VIBHUTI, Arpana
LEAL, Elcio
CHANG, Chung-Ming
RAJ, Vethakkani Samuel
PANDEY, Ramendra Pati
Citação
MINI-REVIEWS IN MEDICINAL CHEMISTRY, v.23, n.2, p.187-191, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Chitin and chitosan have unique structures with significant functional groups carrying useful chemical capabilities. Chitin and chitosan are acknowledged as novel biomaterials with advantageous biocompatibility and biodegradability. Chitosan is a polysaccharide that is made from chitin. There have been several attempts to employ this biopolymer in the biomedical area. This material's application in the production of artificial skin, drug targeting, and other areas is explored. The most prevalent strategies for recovering chitin from sea organisms are described and various pharmacological and biological uses are discussed. This review article targets drug delivery with the help of chitosan derived nanomaterial. The drug delivery system applications through nonmaterial have encountered a considerable role in the pharmaceutical, medical, biological, and other sectors in recent years. Nanomaterials have advanced applications as novel drug delivery systems in many fields, especially in industry, biology, and medicine. In the biomedical and pharmaceutical arena, the natural polymer-based nanoparticulate method has now been widely studied as particulate vehicles. By mixing alginate with other biopolymers, by immobilizing specific molecules such as sugar molecules and peptides by chemical or physical cross-linking, different properties and structures such as biodegradability, gelling properties, mechanical strength, and cell affinity can be obtained. Owing to their inherent ability to deliver both hydrophilic and hydrophobic drug molecules, increase stability, decrease toxicity, and enhance commonly formulated medications, these particles are now widely used in imaging and molecular diagnostics, cosmetics, household chemicals, sunscreens, radiation safety, and novel drug delivery.
Palavras-chave
Biopolymers, physicochemical properties, biological properties, nanomaterials, nanotoxicity, pharmaceutical nanotechnology, toxicological effect
Referências
  1. Ahmed S., 2014, J APPL CHEM, V3, P493
  2. Ampollini L, 2010, EUR J CARDIO-THORAC, V37, P557, DOI 10.1016/j.ejcts.2009.08.012
  3. Bashir S, 2015, REV CHEM ENG, V31, P563, DOI 10.1515/revce-2015-0016
  4. Benhabiles S, 2012, FOOD HYDROCOLLOID, V29, P48, DOI 10.1016/j.foodhyd.2012.02.013
  5. Crini G, 2019, ENVIRON CHEM LETT, V17, P1623, DOI 10.1007/s10311-019-00901-0
  6. Hafdani F.N., 2011, WORLD ACAD SCI ENG T, V50, P252
  7. Ibitoye EB, 2018, BIOMED MATER, V13, DOI 10.1088/1748-605X/aa9dde
  8. Ji JH, 2007, AEROSOL SCI TECH, V41, P786, DOI 10.1080/02786820701459932
  9. Kim YJ, 2009, MOL CELL TOXICOL, V5, P172
  10. Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
  11. Kumirska J, 2011, POLYMERS-BASEL, V3, P1875, DOI 10.3390/polym3041875
  12. Kurita K, 2006, MAR BIOTECHNOL, V8, P203, DOI 10.1007/s10126-005-0097-5
  13. Maliki S, 2022, POLYMERS-BASEL, V14, DOI 10.3390/polym14071475
  14. Morin-Crini N, 2019, ENVIRON CHEM LETT, V17, P1667, DOI 10.1007/s10311-019-00904-x
  15. Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397
  16. Pillai CKS, 2009, PROG POLYM SCI, V34, P641, DOI 10.1016/j.progpolymsci.2009.04.001
  17. Pradeep H, 2022, RSC ADV, V12, P8211, DOI 10.1039/d1ra09317g
  18. Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
  19. Satoh T, 2003, CHEM LETT, V32, P318, DOI 10.1246/cl.2003.318
  20. Toan N.V., 2009, TOBIOMTJ, V1, P21, DOI 10.2174/1876502500901010021
  21. Tsurkan MH, 2021, CARBOHYD POLYM, V252, DOI 10.1016/j.carbpol.2020.117204
  22. VanDenBroek LAM, 2020, WILEY SER RENEW RESO, P1, DOI 10.1002/9781119450467
  23. Younes I, 2015, MAR DRUGS, V13, P1133, DOI 10.3390/md13031133